CAS: 1018946-38-7
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Benzofuran, 2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl)- REF: IN-DA0005U5CAS: 1018946-38-7 | 98% | To inquire | Tue 10 Dec 24 | |
DWK-1339 REF: 3D-TQB94638CAS: 1018946-38-7 | Min. 95% | To inquire | Tue 21 Jan 25 | |
MDR-1339 REF: TM-TQ0026CAS: 1018946-38-7 | 98.57% | 58.00 €~828.00 € | Mon 24 Feb 25 |
Benzofuran, 2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl)-
CAS:1018946-38-7
Formula:
C20H22O4
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
326.3863
Ref: IN-DA0005U5
1mg | 160.00 € | ||
5mg | 299.00 € | ||
10mg | 481.00 € | ||
25mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
DWK-1339
CAS:1018946-38-7
DWK-1339 is a benzofuran derivative with pharmacokinetic properties that resemble those of the benzodiazepine class …
Formula:
C20H22O4
Purity:
Min. 95%
Molecular weight:
326.39 g/mol
Ref: 3D-TQB94638
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
MDR-1339
CAS:1018946-38-7
MDR-1339 is a blood-brain-barrier-permeable inhibitor of amyloid-β (Aβ) aggregation.
Formula:
C20H22O4
Purity:
98.57%
Color and Shape:
Solid
Molecular weight:
326.39
Ref: TM-TQ0026
1mg | 58.00 € | ||
5mg | 122.00 € | ||
10mg | 182.00 € | ||
25mg | 365.00 € | ||
50mg | 551.00 € | ||
100mg | 828.00 € | ||
1mL*10mM (DMSO) | 95.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025